Sopharma AD (BUL:SFA)

Bulgaria flag Bulgaria · Delayed Price · Currency is BGN
2.650
+0.130 (5.16%)
At close: Aug 29, 2025
5.16%
Market Cap1.32B
Revenue (ttm)2.27B
Net Income (ttm)88.47M
Shares Out499.09M
EPS (ttm)0.17
PE Ratio15.75
Forward PEn/a
Dividend0.05 (1.98%)
Ex-Dividend DateJul 10, 2025
Volume117,487
Average Volume296,880
Open2.530
Previous Close2.520
Day's Range2.530 - 2.660
52-Week Range1.840 - 2.700
Beta-0.16
RSI81.89
Earnings DateAug 30, 2025

About Sopharma AD

Sopharma AD produces, distributes, and exports pharmaceutical products in Europe, Bulgaria, and internationally. It offers Carsil to treat liver disease; Tempalgin, a painkiller; Analgin, a pain reliever; Tabex, a drug used for smoking secession; Tribestan, a drug used for stimulation of the male reproductive system; Broncholytin, which is used to suppress cough; Nivalin for use in the peripheral nervous system; Methylprednisolon for severe allergies and life-threatening conditions; Vitamin C; Valeriana to reduce the stress; and medical devices... [Read more]

Industry Pharmaceutical Preparations
Founded 1933
Employees 5,599
Stock Exchange Bulgarian Stock Exchange
Ticker Symbol SFA
Full Company Profile

Financial Performance

In 2024, Sopharma AD's revenue was 2.14 billion, an increase of 13.27% compared to the previous year's 1.89 billion. Earnings were 77.85 million, a decrease of -18.89%.

Financial Statements

News

There is no news available yet.